智通财经APP讯，亚盛医药-B(06855)发布公告，王章旗已辞任(i)公司秘书;(ii)香港联合交易所有限公司证券上市规则第3.05条规定的授权代表;及(iii)香港法例第622章公司条例第16部下获授权代表公司接收法律程序文件及通知书的人士及上市规则第19.05(2)条下代表公司接受法律程序文件及通知书的授权代表，均自2025年2月25日起生效。
随王先生辞任后，陈焯墁已获委任为公司秘书、3.05条授权代表及公司条例及19.05条授权代表，均自2025年2月25日起生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.